Literature DB >> 11127507

Serologic response to Blastocystis hominis infection in asymptomatic individuals.

Y Kaneda1, N Horiki, X Cheng, H Tachibana, Y Tsutsumi.   

Abstract

The pathogenic potential of Blastocystis hominis in the human intestine is subject to controversy because the organism has been found in both symptomatic and asymptomatic individuals. To help clarify this issue, we monitored the serologic response to the organism in B. hominis-infected individuals free of gastroenterologic disorders. 1) Serum antibodies to B. hominis were detected in 70% of infected asymptomatic individuals by an indirect immunofluorescence (IFA) test. 2) IFA and immunoelectron microscopy revealed that the antibody response was directed against a surface antigen(s) of the organism. 3) Analysis by immunoblotting implicated a 12 kDa protein of B. hominis. 4) The strongest positive reaction was obtained in an individual chronically infected for more than 2 years. It may be that long exposure to the parasite is necessary for a serologic response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127507

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  11 in total

1.  The potential use of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis.

Authors:  Maha M Abou Gamra; Hala S Elwakil; Hala K El Deeb; Khalifa E Khalifa; Hala E Abd Elhafiz
Journal:  Parasitol Res       Date:  2010-12-07       Impact factor: 2.289

2.  Epidemiological survey of Blastocystis hominis in Huainan City, Anhui Province, China.

Authors:  Ke-Xia Wang; Chao-Pin Li; Jian Wang; Yu-Bao Cui
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Kinetic analysis of antibody responses to Blastocystis hominis in sera and intestinal secretions of orally infected mice.

Authors:  Herbert J Santos; Windell L Rivera
Journal:  Parasitol Res       Date:  2009-07-14       Impact factor: 2.289

4.  Molecular Epidemiology and Risk Factors of Blastocystis sp. Infections Among General Populations in Yunnan Province, Southwestern China.

Authors:  Yao Deng; Shunxian Zhang; Chaoqun Ning; Yongkang Zhou; Xuejiao Teng; Xiuping Wu; Yanhong Chu; Yingfang Yu; Jiaxu Chen; Liguang Tian; Wei Wang
Journal:  Risk Manag Healthc Policy       Date:  2020-09-29

Review 5.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro.

Authors:  Hala K El Deeb; Faisal M Al Khadrawy; Ayman K Abd El-Hameid
Journal:  Parasitol Res       Date:  2012-05-15       Impact factor: 2.289

7.  Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls.

Authors:  Robyn Nagel; Rebecca J Traub; Marcella M S Kwan; Helle Bielefeldt-Ohmann
Journal:  Parasit Vectors       Date:  2015-09-15       Impact factor: 3.876

8.  Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7.

Authors:  Zhaona Wu; Haris Mirza; Kevin Shyong Wei Tan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22

Review 9.  Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity?

Authors:  M Lepczyńska; J Białkowska; E Dzika; K Piskorz-Ogórek; J Korycińska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-22       Impact factor: 3.267

10.  Blastocystis prevalence and subtypes in autochthonous and immigrant patients in a referral centre for parasitic infections in Italy.

Authors:  Chiara Piubelli; Hossein Soleymanpoor; Giovanni Giorli; Fabio Formenti; Dora Buonfrate; Zeno Bisoffi; Francesca Perandin
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.